chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood fibrinogen, COVID-19, Chest X-ray normal, Fibrin D dimer, Red blood cell sedimentation rate increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11 Moderna , dose #1 03/15, Moderna , dose #2 02/15 COVID swab, result: NOT detected 09/18 FIBRINOGEN: 331 09/18 DDIMER: 0.84 09/18 ERRITIN 330.8 09/18 COVID swab, result: detected 09/19 TROPONIN I <0.016 09/19 FIBRINGOGEN: 317 09/19 DDIMER: 0.77 09/19 ESR 29 09/20 FIBRINOGEN: 342 09/20 DDIMER: 0.77 09/20 ESR 33 09/20 COVID swab, result: not detected 08/03 PT cc: exposure: unknown 09/18 CXR impression: No acute cardiopulmonary findings.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Troponin I normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11 Moderna , dose #1 03/15, Moderna , dose #2 02/15 COVID swab, result: NOT detected 09/18 FIBRINOGEN: 331 09/18 DDIMER: 0.84 09/18 ERRITIN 330.8 09/18 COVID swab, result: detected 09/19 TROPONIN I <0.016 09/19 FIBRINGOGEN: 317 09/19 DDIMER: 0.77 09/19 ESR 29 09/20 FIBRINOGEN: 342 09/20 DDIMER: 0.77 09/20 ESR 33 09/20 COVID swab, result: not detected 08/03 PT cc: exposure: unknown 09/18 CXR impression: No acute cardiopulmonary findings.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, DOSE #1 04/06, Pfizer, dose #2 09/20 pt cc: chills, cough, fatigue, diarrhea, fever, headache, myalgias, rhinorrhea, congestion, sore thorat, exposure: unknown 09/21 COVID swab, result: detected 09/21 SARS-COV Variant Sequencing result: pending 09/23 COVID swab, result: detected clinically resolved
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Laboratory test, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, DOSE #1 04/06, Pfizer, dose #2 09/20 pt cc: chills, cough, fatigue, diarrhea, fever, headache, myalgias, rhinorrhea, congestion, sore thorat, exposure: unknown 09/21 COVID swab, result: detected 09/21 SARS-COV Variant Sequencing result: pending 09/23 COVID swab, result: detected clinically resolved
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, DOSE #1 04/06, Pfizer, dose #2 09/20 pt cc: chills, cough, fatigue, diarrhea, fever, headache, myalgias, rhinorrhea, congestion, sore thorat, exposure: unknown 09/21 COVID swab, result: detected 09/21 SARS-COV Variant Sequencing result: pending 09/23 COVID swab, result: detected clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/31/2020, Pfizer, dose #1 01/25/2021, Pfizer dose #2 09/22 pt cc: chills, cough, diarrhea, fatigue, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown 09/23 COVID swab, result: detected 09/23 COVID-19 Ag: not detected 09/23 SARS-COV-2 Variant Sequencing result: pending
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Myalgia, Rhinorrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/31/2020, Pfizer, dose #1 01/25/2021, Pfizer dose #2 09/22 pt cc: chills, cough, diarrhea, fatigue, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown 09/23 COVID swab, result: detected 09/23 COVID-19 Ag: not detected 09/23 SARS-COV-2 Variant Sequencing result: pending
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/31/2020, Pfizer, dose #1 01/25/2021, Pfizer dose #2 09/22 pt cc: chills, cough, diarrhea, fatigue, loss of taste or smell, myalgias, rhinorrhea, dyspnea exposure: unknown 09/23 COVID swab, result: detected 09/23 COVID-19 Ag: not detected 09/23 SARS-COV-2 Variant Sequencing result: pending
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID Positive
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/07, Pfizer, dose #2 09/23 pt cc: chills, cough, fatigue, fever, loss of taste or smell, rhinorrhea, congestion exposure: Possible from student. 09/24 COVID swab, result: detected 09/24 SARS-COV-2 Variant Sequencing result: pending
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/07, Pfizer, dose #2 09/23 pt cc: chills, cough, fatigue, fever, loss of taste or smell, rhinorrhea, congestion exposure: Possible from student. 09/24 COVID swab, result: detected 09/24 SARS-COV-2 Variant Sequencing result: pending
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/25, Pfizer, dose#1 04/14. Pfizer, dose #2 09/27 COVID swab, result: detected 09/27 pt cc: exposure: unknown
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/29.2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 08/27/2021, Pfizer, dose #3 COVID swab, result: detected 09/24 pt cc: cough, fatigue, myalgias, dyspnea, fatigue, fever, exposure: unknown clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 12/29.2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 08/27/2021, Pfizer, dose #3 COVID swab, result: detected 09/24 pt cc: cough, fatigue, myalgias, dyspnea, fatigue, fever, exposure: unknown clinically resolved
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/25 Pfizer, dose healthcare professional #1 02/16, Pfizer, dose #2 09/27 COVID swab, result: detected 09/22 pt cc: chills, cough, fatigue, fever headache, loss of taste or smell, myalgias, sore throat exposure: unknown clinically resolved
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/25 Pfizer, dose healthcare professional #1 02/16, Pfizer, dose #2 09/27 COVID swab, result: detected 09/22 pt cc: chills, cough, fatigue, fever headache, loss of taste or smell, myalgias, sore throat exposure: unknown clinically resolved
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/25 Pfizer, dose healthcare professional #1 02/16, Pfizer, dose #2 09/27 COVID swab, result: detected 09/22 pt cc: chills, cough, fatigue, fever headache, loss of taste or smell, myalgias, sore throat exposure: unknown clinically resolved
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Moderna , dose #1 03/16, Moderna, dose #2 10/28, dose #3 09/30 COVID swab, result: detected 09/27 pt cc: cough, fatigue, headache, myalgias, rhinorrhea, dyspnea exposure: unknown clinically resolved
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Moderna , dose #1 03/16, Moderna, dose #2 10/28, dose #3 09/30 COVID swab, result: detected 09/27 pt cc: cough, fatigue, headache, myalgias, rhinorrhea, dyspnea exposure: unknown clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen normal, Blood lactic acid, Brain natriuretic peptide increased, COVID-19, Chest X-ray normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 10/01 pt cc: exposure: unknown 10/01 COVID swab, result: detected 10/01 CXR Impression: No acute abnormality or change since July 2021 10/01 BNP: 1145.6 10/02 FIBRINOGEN: 304 10/02 DDIMER: 1.26 10/02 LACTIC ACID: 1.35 10/02 ESR: 92 10/03 SARS-COV-2 IgG: 0.35 10/04 CXR Impression: No pneumonia. 10/04 COVID swab, result: NOT detected 10/07 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 10/01 pt cc: exposure: unknown 10/01 COVID swab, result: detected 10/01 CXR Impression: No acute abnormality or change since July 2021 10/01 BNP: 1145.6 10/02 FIBRINOGEN: 304 10/02 DDIMER: 1.26 10/02 LACTIC ACID: 1.35 10/02 ESR: 92 10/03 SARS-COV-2 IgG: 0.35 10/04 CXR Impression: No pneumonia. 10/04 COVID swab, result: NOT detected 10/07 clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Fatigue, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11, Moderna , dose #1 03/11 , Moderna, dose #2 09/29 pt cc: cough, diarrhea, fatigue, myalgias,  rhinorrhea, exposure: unknown 10/01 SARS-COV-2 Variant Sequencing result: pending 10/01 COVID swab, result: detected 10/9 clinically resolved
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/11, Moderna , dose #1 03/11 , Moderna, dose #2 09/29 pt cc: cough, diarrhea, fatigue, myalgias,  rhinorrhea, exposure: unknown 10/01 SARS-COV-2 Variant Sequencing result: pending 10/01 COVID swab, result: detected 10/9 clinically resolved
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriosclerosis coronary artery, COVID-19, Cardiomegaly, Chest X-ray abnormal, Computerised tomogram thorax abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/23, Pfizer, dose #1 02/12, Pfizer, dose #2 09/03 pt cc cough, rhinorrhea, dyspnea, exposure: unknown 09/22 COVID swab, result: detected 09/22 CXR impression: Findings: Reticulonodular opacities are now noted projecting over the right midlung region new since previous examination. Negative for pneumothorax, airspace disease, atelectasis, effusions or edema. The heart size and configuration are normal. Mediastinum and pleural spaces are normal. No masses, nodules or adenopathy detected. The visualized bones are normal for the patient's age. Impression: Nonspecific reticulonodular opacities in the right midlung. Recommend CT scan to better evaluate 09/29 clinically resolved 10/07 CT Chest impression: The lungs demonstrate no consolidation, masses or effusions. There are ill-defined areas of groundglass in the dependent portions of the right lower lobe. The heart is mildly enlarged globally. Extensive coronary artery calcifications. There is no evidence of pericardial effusion. No significant pneumothorax. No significant mediastinal adenopathy or soft tissue mass. The visualized osseous structures show no lytic or blastic lesions. No acute osseous abnormality visualized. The visualized portions of the abdomen appear normal. Impression: 1. Patchy bilateral perihilar and lower viral infection (Covid 19). 2. Coronary artery disease. Cardiomegaly. 09/22 SARS-COV-2 Variant Sequencing result: pending.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery disease, Cough, Dyspnoea, Lung opacity, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/23, Pfizer, dose #1 02/12, Pfizer, dose #2 09/03 pt cc cough, rhinorrhea, dyspnea, exposure: unknown 09/22 COVID swab, result: detected 09/22 CXR impression: Findings: Reticulonodular opacities are now noted projecting over the right midlung region new since previous examination. Negative for pneumothorax, airspace disease, atelectasis, effusions or edema. The heart size and configuration are normal. Mediastinum and pleural spaces are normal. No masses, nodules or adenopathy detected. The visualized bones are normal for the patient's age. Impression: Nonspecific reticulonodular opacities in the right midlung. Recommend CT scan to better evaluate 09/29 clinically resolved 10/07 CT Chest impression: The lungs demonstrate no consolidation, masses or effusions. There are ill-defined areas of groundglass in the dependent portions of the right lower lobe. The heart is mildly enlarged globally. Extensive coronary artery calcifications. There is no evidence of pericardial effusion. No significant pneumothorax. No significant mediastinal adenopathy or soft tissue mass. The visualized osseous structures show no lytic or blastic lesions. No acute osseous abnormality visualized. The visualized portions of the abdomen appear normal. Impression: 1. Patchy bilateral perihilar and lower viral infection (Covid 19). 2. Coronary artery disease. Cardiomegaly. 09/22 SARS-COV-2 Variant Sequencing result: pending.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/23, Pfizer, dose #1 02/12, Pfizer, dose #2 09/03 pt cc cough, rhinorrhea, dyspnea, exposure: unknown 09/22 COVID swab, result: detected 09/22 CXR impression: Findings: Reticulonodular opacities are now noted projecting over the right midlung region new since previous examination. Negative for pneumothorax, airspace disease, atelectasis, effusions or edema. The heart size and configuration are normal. Mediastinum and pleural spaces are normal. No masses, nodules or adenopathy detected. The visualized bones are normal for the patient's age. Impression: Nonspecific reticulonodular opacities in the right midlung. Recommend CT scan to better evaluate 09/29 clinically resolved 10/07 CT Chest impression: The lungs demonstrate no consolidation, masses or effusions. There are ill-defined areas of groundglass in the dependent portions of the right lower lobe. The heart is mildly enlarged globally. Extensive coronary artery calcifications. There is no evidence of pericardial effusion. No significant pneumothorax. No significant mediastinal adenopathy or soft tissue mass. The visualized osseous structures show no lytic or blastic lesions. No acute osseous abnormality visualized. The visualized portions of the abdomen appear normal. Impression: 1. Patchy bilateral perihilar and lower viral infection (Covid 19). 2. Coronary artery disease. Cardiomegaly. 09/22 SARS-COV-2 Variant Sequencing result: pending.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Lung opacity, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 09/23 COVID swab, result: detected 09/23 pt cc: Myalgias exposure: unknown 09/23 CXR impression: 1. Mild left lower lobe atelectasis. Suggest follow-up PA and lateral chest radiographs, if the patient is able. 09/23 CXR impression: 1. Similar left basilar opacity, presumably atelectasis. 2. If symptoms persist, consider follow-up or secondary imaging. 09/23 Troponin I: <0.016
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin I normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/12, Pfizer, dose #1 03/05, Pfizer, dose #2 09/23 COVID swab, result: detected 09/23 pt cc: Myalgias exposure: unknown 09/23 CXR impression: 1. Mild left lower lobe atelectasis. Suggest follow-up PA and lateral chest radiographs, if the patient is able. 09/23 CXR impression: 1. Similar left basilar opacity, presumably atelectasis. 2. If symptoms persist, consider follow-up or secondary imaging. 09/23 Troponin I: <0.016
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/01, Pfizer, dose #1 02/22, Pfizer, dose #2 04/05 COVID swab, result: not detected 09/23 pt cc: chills, fatigue, sore throat exposure: unknown 09/23 SARS-COV-2 Variant Sequencing result: pending 09/23 COVID swab, result: detected
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fibrin D dimer increased, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/30, Pfizer, dose #1 05/21, Pfizer, dose #2 09/24 COVID swab, result: detected 09/24 pt cc: exposure: unknown 09/24 COVID swab, result: detected 09/26 COVID swab, result: detected 09/26 SARS-COV-2 Variant Sequencing result: pending 09/26 SARS-CO-COV-2 IgG: 4.05 09/27 DDIMER: 0.44 10/22 clinically resolved 10/12 BinaxNOW COVID-19 Ag: not detected 10/14 BinaxNOW COVID-19 Ag: not detected 10/15 BinaxNOW COVID-19 Ag: not detected 11/02 BinaxNOW COVID-19 Ag: not detected 10/26 BinaxNOW COVID-19 Ag: not detected 10/29 BinaxNOW COVID-19 Ag: not detected 11/02 BinaxNOW COVID-19 Ag: not detected 11/05 BinaxNOW COVID-19 Ag: not detected
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/07, Moderna, dose #1 05/04, Moderna, dose #2 09/24 COVID swab, result: detected 09/24 pt cc: exposure: unknown
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Asthenia, Benign prostatic hyperplasia, Bladder catheterisation, Bladder outlet obstruction
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen normal, Blood lactate dehydrogenase increased, Blood lactic acid, Brain natriuretic peptide normal, C-reactive protein increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray normal, Computerised tomogram abdomen abnormal, Confusional state
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Cystitis, Decreased appetite, Fibrin D dimer, Hypophagia, International normalised ratio increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Prostatomegaly, Prothrombin time prolonged, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Troponin I increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/29, Pfizer, dose #1 04/19, Pfizer, dose #2 09/13 pt cc: weakness, bodyache, no appetite, confusion: unknown 09/20 pt admit to medicine cc: weakness and decrease PO intake x 7 days dx: COVID 19 infection LOS: 4 days 09/20 LIPASE: 30 09/20 COVID-19 ANTIGEN (BINAX): DETECTED 09/20 LACTIC ACID: 1.95 09/20 PT/INR 15.3/1.37 09/20 TROPONIN I: 0.042 09/20 DDIMER: 1.17 09/20 FERITIN: 1227.2 09/20 LDH: 429.9 09/20 CRP: 5.535 09/20 FIBRINOGEN: 326 09/20 BNP result: <10.0 09/20 SARS-COV-2 IgG result: 0.47 09/20 SARS-COV-2 TOTAL AB, SPIKE result: .2500.00 09/20 CXR impression: No focal consolidation. 09/21 CTA PE impression: 1. No pulmonary embolus to the subsegmental level. 2. Imaging findings consistent with ongoing COVID pneumonitis. No pleural effusion. ABDOMEN/PELVIS: Imaging findings consistent with a combination of chronic cystitis and bladder outlet obstructive disease. Urinary bladder is mostly collapsed about an indwelling Foley catheter balloon. No imaging findings of pyelitis, pyelonephritis or renal abscess. Marked prostatomegaly with changes of benign prostatic hyperplasia. Normal seminal vesicles. Remainder of findings as above. 09/21 COVID swab, result: detected 09/21 FIBRINOGEN: 449 09/21 DDIMER: 0.79 09/21 ESR: 45 09/21TROPONIN I: 0.025 09/22 FIBRINOGEN: 399 09/22 DDIMER: 0.63 09/22 ESR: 24 09/23 FIBRINOGEN: 336 09/23 DDIMER: 0.59 09/23 ESR: 5 09/24 FIBRINOGEN: 321 09/24 DDIMER 0.65 09/24 ESR:24
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/07 Janssen, dose #1 09/21 COVID swab, result: detected 09/20 pt cc: chills,  cough, fatigue, myalgias, sore throat exposure: unknown
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/07 Janssen, dose #1 09/21 COVID swab, result: detected 09/20 pt cc: chills,  cough, fatigue, myalgias, sore throat exposure: unknown
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/03, Moderna , dose #1 03/31, Moderna, dose #2 09/08 pt cc: chills, cough, fatigue, myalgias, fever, loss of taste or smell, diarrhea, headache nausea, rhinorrhea exposure: unknown 09/21 COVID swab, result: detected 09/21 SARS-COV-2 Variant Sequencing result: pending
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/03, Moderna , dose #1 03/31, Moderna, dose #2 09/08 pt cc: chills, cough, fatigue, myalgias, fever, loss of taste or smell, diarrhea, headache nausea, rhinorrhea exposure: unknown 09/21 COVID swab, result: detected 09/21 SARS-COV-2 Variant Sequencing result: pending
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/03, Moderna , dose #1 03/31, Moderna, dose #2 09/08 pt cc: chills, cough, fatigue, myalgias, fever, loss of taste or smell, diarrhea, headache nausea, rhinorrhea exposure: unknown 09/21 COVID swab, result: detected 09/21 SARS-COV-2 Variant Sequencing result: pending
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, COVID-19, COVID-19 pneumonia, Hypoxia
Clinical narrative: Narrative: Patient received two doses of COVID 19 vaccine in Feb/Mar 2021. The patient tested positive for COVID 19 on 27 Oct 21 and was hospitalized on 2 November 2021 with hypoxemia, loss of taste and smell, myalgia, and COVID pneumonia. The patient was discharged on oxygen on 7 November 2021.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient received two doses of COVID 19 vaccine in Feb/Mar 2021. The patient tested positive for COVID 19 on 27 Oct 21 and was hospitalized on 2 November 2021 with hypoxemia, loss of taste and smell, myalgia, and COVID pneumonia. The patient was discharged on oxygen on 7 November 2021.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 10/20, Pfizer, dose #3 09/19 10/15 COVID swab, result: NOT detected 09/22 pt cc: chills, cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias, nausea, rhinorrhea dyspnea, sore throat vomiting exposure: unknown 09/22 COVID swab, result: detected 10/12 COVID swab, result: NOT detected 10/15 COVID swab, result: NOT detected
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 10/20, Pfizer, dose #3 09/19 10/15 COVID swab, result: NOT detected 09/22 pt cc: chills, cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias, nausea, rhinorrhea dyspnea, sore throat vomiting exposure: unknown 09/22 COVID swab, result: detected 10/12 COVID swab, result: NOT detected 10/15 COVID swab, result: NOT detected
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 10/20, Pfizer, dose #3 09/19 10/15 COVID swab, result: NOT detected 09/22 pt cc: chills, cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias, nausea, rhinorrhea dyspnea, sore throat vomiting exposure: unknown 09/22 COVID swab, result: detected 10/12 COVID swab, result: NOT detected 10/15 COVID swab, result: NOT detected
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/17, Pfizer, dose #1 03/10, Pfizer, dose #2 10/20, Pfizer, dose #3 09/19 10/15 COVID swab, result: NOT detected 09/22 pt cc: chills, cough, diarrhea, fatigue, fever, headache, loss of taste or smell, myalgias, nausea, rhinorrhea dyspnea, sore throat vomiting exposure: unknown 09/22 COVID swab, result: detected 10/12 COVID swab, result: NOT detected 10/15 COVID swab, result: NOT detected
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute left ventricular failure, Acute respiratory failure, Angiogram pulmonary abnormal, Blood fibrinogen increased, Blood lactic acid
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 09/22 cc: dx: Acute hypoxic respiratory failure, COVID Pneumonia in a vaccinated patient, ACUTE DECOMPENSATED SYSTOLIC CHF, improved. LOS: 5 days 09/22 pt cc: cough, fatigue, dyspnea, fever, exposure: unknown 09/22 BinaxNOW COVID-19 Ag: NOT DETECTED 09/22 PT/INR 12.1/1.08 09/22 BNP: 963.3 09/22 FIBRINOGEN: 422 09/22 DDIMER: 1.60 09/22 LACTTIC ACID: 1.42 09/22 FERRITIN: 94.5 09/22 COVID swab, result: detected 09/22 SARS-COV-2 IGG Eval: 6.25 09/22 SARS-COV-2 TOTAL AB, SPIKE result: >2500.0 09/22 CTA PE impression: teral pneumonia. Please correlate with Covid status. 09/23 FIBRINOGEN: 431 09/23 DDIMER: 1.79 09/23 ESR: 35 09/23 TROPONIN I: <0.016 09/24 CXR impression Bila 1. No evidence of pulmonary embolism. 2. Bilateral peribronchial consolidation. Groundglass opacities in the periphery, more than expected for simply interstitial lung disease. This is concerning for pneumonia including COVID-19. Correlate clinically. 3. Findings compatible with UIP pattern interstitial lung disease, worsened since March 2020. teral mixed interstitial and airspace opacities with a lower lung predominance, similar to prior. Otherwise no pneumothorax or large pleural effusion. Stable cardiomediastinal silhouette. Osseous structures grossly stable with partially imaged cervical fusion hardware and vertebral cement. 09/24 FIBRINOGEN: 308 09/24 DDIMER: 1.05 09/24 ESR: 51 09/24 IONIZED: 1.05 09/25 FIBRINOGEN: 292 09/25 DDIMER: 1.00 09/25 ESR: 38 09/26 FIBRINOGEN: 308 09/26 DDIMER: 1.04 09/26 ESR: 18 09/27 COVID swab, result: NOT detected 09/27 FIBRINOGEN: 284 09/27 DDIMER: 0.84 09/27 ESR: 32
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 09/22 cc: dx: Acute hypoxic respiratory failure, COVID Pneumonia in a vaccinated patient, ACUTE DECOMPENSATED SYSTOLIC CHF, improved. LOS: 5 days 09/22 pt cc: cough, fatigue, dyspnea, fever, exposure: unknown 09/22 BinaxNOW COVID-19 Ag: NOT DETECTED 09/22 PT/INR 12.1/1.08 09/22 BNP: 963.3 09/22 FIBRINOGEN: 422 09/22 DDIMER: 1.60 09/22 LACTTIC ACID: 1.42 09/22 FERRITIN: 94.5 09/22 COVID swab, result: detected 09/22 SARS-COV-2 IGG Eval: 6.25 09/22 SARS-COV-2 TOTAL AB, SPIKE result: >2500.0 09/22 CTA PE impression: teral pneumonia. Please correlate with Covid status. 09/23 FIBRINOGEN: 431 09/23 DDIMER: 1.79 09/23 ESR: 35 09/23 TROPONIN I: <0.016 09/24 CXR impression Bila 1. No evidence of pulmonary embolism. 2. Bilateral peribronchial consolidation. Groundglass opacities in the periphery, more than expected for simply interstitial lung disease. This is concerning for pneumonia including COVID-19. Correlate clinically. 3. Findings compatible with UIP pattern interstitial lung disease, worsened since March 2020. teral mixed interstitial and airspace opacities with a lower lung predominance, similar to prior. Otherwise no pneumothorax or large pleural effusion. Stable cardiomediastinal silhouette. Osseous structures grossly stable with partially imaged cervical fusion hardware and vertebral cement. 09/24 FIBRINOGEN: 308 09/24 DDIMER: 1.05 09/24 ESR: 51 09/24 IONIZED: 1.05 09/25 FIBRINOGEN: 292 09/25 DDIMER: 1.00 09/25 ESR: 38 09/26 FIBRINOGEN: 308 09/26 DDIMER: 1.04 09/26 ESR: 18 09/27 COVID swab, result: NOT detected 09/27 FIBRINOGEN: 284 09/27 DDIMER: 0.84 09/27 ESR: 32
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Condition aggravated, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 09/22 cc: dx: Acute hypoxic respiratory failure, COVID Pneumonia in a vaccinated patient, ACUTE DECOMPENSATED SYSTOLIC CHF, improved. LOS: 5 days 09/22 pt cc: cough, fatigue, dyspnea, fever, exposure: unknown 09/22 BinaxNOW COVID-19 Ag: NOT DETECTED 09/22 PT/INR 12.1/1.08 09/22 BNP: 963.3 09/22 FIBRINOGEN: 422 09/22 DDIMER: 1.60 09/22 LACTTIC ACID: 1.42 09/22 FERRITIN: 94.5 09/22 COVID swab, result: detected 09/22 SARS-COV-2 IGG Eval: 6.25 09/22 SARS-COV-2 TOTAL AB, SPIKE result: >2500.0 09/22 CTA PE impression: teral pneumonia. Please correlate with Covid status. 09/23 FIBRINOGEN: 431 09/23 DDIMER: 1.79 09/23 ESR: 35 09/23 TROPONIN I: <0.016 09/24 CXR impression Bila 1. No evidence of pulmonary embolism. 2. Bilateral peribronchial consolidation. Groundglass opacities in the periphery, more than expected for simply interstitial lung disease. This is concerning for pneumonia including COVID-19. Correlate clinically. 3. Findings compatible with UIP pattern interstitial lung disease, worsened since March 2020. teral mixed interstitial and airspace opacities with a lower lung predominance, similar to prior. Otherwise no pneumothorax or large pleural effusion. Stable cardiomediastinal silhouette. Osseous structures grossly stable with partially imaged cervical fusion hardware and vertebral cement. 09/24 FIBRINOGEN: 308 09/24 DDIMER: 1.05 09/24 ESR: 51 09/24 IONIZED: 1.05 09/25 FIBRINOGEN: 292 09/25 DDIMER: 1.00 09/25 ESR: 38 09/26 FIBRINOGEN: 308 09/26 DDIMER: 1.04 09/26 ESR: 18 09/27 COVID swab, result: NOT detected 09/27 FIBRINOGEN: 284 09/27 DDIMER: 0.84 09/27 ESR: 32
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, International normalised ratio normal, Interstitial lung disease, Lung consolidation, Lung opacity
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 09/22 cc: dx: Acute hypoxic respiratory failure, COVID Pneumonia in a vaccinated patient, ACUTE DECOMPENSATED SYSTOLIC CHF, improved. LOS: 5 days 09/22 pt cc: cough, fatigue, dyspnea, fever, exposure: unknown 09/22 BinaxNOW COVID-19 Ag: NOT DETECTED 09/22 PT/INR 12.1/1.08 09/22 BNP: 963.3 09/22 FIBRINOGEN: 422 09/22 DDIMER: 1.60 09/22 LACTTIC ACID: 1.42 09/22 FERRITIN: 94.5 09/22 COVID swab, result: detected 09/22 SARS-COV-2 IGG Eval: 6.25 09/22 SARS-COV-2 TOTAL AB, SPIKE result: >2500.0 09/22 CTA PE impression: teral pneumonia. Please correlate with Covid status. 09/23 FIBRINOGEN: 431 09/23 DDIMER: 1.79 09/23 ESR: 35 09/23 TROPONIN I: <0.016 09/24 CXR impression Bila 1. No evidence of pulmonary embolism. 2. Bilateral peribronchial consolidation. Groundglass opacities in the periphery, more than expected for simply interstitial lung disease. This is concerning for pneumonia including COVID-19. Correlate clinically. 3. Findings compatible with UIP pattern interstitial lung disease, worsened since March 2020. teral mixed interstitial and airspace opacities with a lower lung predominance, similar to prior. Otherwise no pneumothorax or large pleural effusion. Stable cardiomediastinal silhouette. Osseous structures grossly stable with partially imaged cervical fusion hardware and vertebral cement. 09/24 FIBRINOGEN: 308 09/24 DDIMER: 1.05 09/24 ESR: 51 09/24 IONIZED: 1.05 09/25 FIBRINOGEN: 292 09/25 DDIMER: 1.00 09/25 ESR: 38 09/26 FIBRINOGEN: 308 09/26 DDIMER: 1.04 09/26 ESR: 18 09/27 COVID swab, result: NOT detected 09/27 FIBRINOGEN: 284 09/27 DDIMER: 0.84 09/27 ESR: 32
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Prothrombin time prolonged, Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test, SARS-CoV-2 test negative
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 09/22 cc: dx: Acute hypoxic respiratory failure, COVID Pneumonia in a vaccinated patient, ACUTE DECOMPENSATED SYSTOLIC CHF, improved. LOS: 5 days 09/22 pt cc: cough, fatigue, dyspnea, fever, exposure: unknown 09/22 BinaxNOW COVID-19 Ag: NOT DETECTED 09/22 PT/INR 12.1/1.08 09/22 BNP: 963.3 09/22 FIBRINOGEN: 422 09/22 DDIMER: 1.60 09/22 LACTTIC ACID: 1.42 09/22 FERRITIN: 94.5 09/22 COVID swab, result: detected 09/22 SARS-COV-2 IGG Eval: 6.25 09/22 SARS-COV-2 TOTAL AB, SPIKE result: >2500.0 09/22 CTA PE impression: teral pneumonia. Please correlate with Covid status. 09/23 FIBRINOGEN: 431 09/23 DDIMER: 1.79 09/23 ESR: 35 09/23 TROPONIN I: <0.016 09/24 CXR impression Bila 1. No evidence of pulmonary embolism. 2. Bilateral peribronchial consolidation. Groundglass opacities in the periphery, more than expected for simply interstitial lung disease. This is concerning for pneumonia including COVID-19. Correlate clinically. 3. Findings compatible with UIP pattern interstitial lung disease, worsened since March 2020. teral mixed interstitial and airspace opacities with a lower lung predominance, similar to prior. Otherwise no pneumothorax or large pleural effusion. Stable cardiomediastinal silhouette. Osseous structures grossly stable with partially imaged cervical fusion hardware and vertebral cement. 09/24 FIBRINOGEN: 308 09/24 DDIMER: 1.05 09/24 ESR: 51 09/24 IONIZED: 1.05 09/25 FIBRINOGEN: 292 09/25 DDIMER: 1.00 09/25 ESR: 38 09/26 FIBRINOGEN: 308 09/26 DDIMER: 1.04 09/26 ESR: 18 09/27 COVID swab, result: NOT detected 09/27 FIBRINOGEN: 284 09/27 DDIMER: 0.84 09/27 ESR: 32
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin normal, Troponin I normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/10, Pfizer, dose #1 03/03, Pfizer, dose #2 09/22 cc: dx: Acute hypoxic respiratory failure, COVID Pneumonia in a vaccinated patient, ACUTE DECOMPENSATED SYSTOLIC CHF, improved. LOS: 5 days 09/22 pt cc: cough, fatigue, dyspnea, fever, exposure: unknown 09/22 BinaxNOW COVID-19 Ag: NOT DETECTED 09/22 PT/INR 12.1/1.08 09/22 BNP: 963.3 09/22 FIBRINOGEN: 422 09/22 DDIMER: 1.60 09/22 LACTTIC ACID: 1.42 09/22 FERRITIN: 94.5 09/22 COVID swab, result: detected 09/22 SARS-COV-2 IGG Eval: 6.25 09/22 SARS-COV-2 TOTAL AB, SPIKE result: >2500.0 09/22 CTA PE impression: teral pneumonia. Please correlate with Covid status. 09/23 FIBRINOGEN: 431 09/23 DDIMER: 1.79 09/23 ESR: 35 09/23 TROPONIN I: <0.016 09/24 CXR impression Bila 1. No evidence of pulmonary embolism. 2. Bilateral peribronchial consolidation. Groundglass opacities in the periphery, more than expected for simply interstitial lung disease. This is concerning for pneumonia including COVID-19. Correlate clinically. 3. Findings compatible with UIP pattern interstitial lung disease, worsened since March 2020. teral mixed interstitial and airspace opacities with a lower lung predominance, similar to prior. Otherwise no pneumothorax or large pleural effusion. Stable cardiomediastinal silhouette. Osseous structures grossly stable with partially imaged cervical fusion hardware and vertebral cement. 09/24 FIBRINOGEN: 308 09/24 DDIMER: 1.05 09/24 ESR: 51 09/24 IONIZED: 1.05 09/25 FIBRINOGEN: 292 09/25 DDIMER: 1.00 09/25 ESR: 38 09/26 FIBRINOGEN: 308 09/26 DDIMER: 1.04 09/26 ESR: 18 09/27 COVID swab, result: NOT detected 09/27 FIBRINOGEN: 284 09/27 DDIMER: 0.84 09/27 ESR: 32
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/03 Janssen, dose #1 09/12 pt cc: chills, cough, fatigue, fever, headache, rhinorrhea, sore throat exposure: unknown 09/17 COVID swab, result: detected 09/21 clinically resolved
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 07/03 Janssen, dose #1 09/12 pt cc: chills, cough, fatigue, fever, headache, rhinorrhea, sore throat exposure: unknown 09/17 COVID swab, result: detected 09/21 clinically resolved
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Red blood cell sedimentation rate normal, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/09, Pfizer, dose #1 03/30, Pfizer, dose #2 10/15, Pfizer, dose #3 08/11 09/18 COVID swab, result: detected NON-FACILITY 09/17 ESR 4 09/18 COVID swab, result: detected 09/18 pt cc: exposure: unknown 09/19 clinically resolved
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Angiogram pulmonary abnormal, Anosmia, Blood bicarbonate normal, Blood fibrinogen increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/19, Pfizer, dose #2 07/13 COVID swab, result: not detected 08/31, Pfizer, dose #3 09/18 SARS-COV-2 Variant Sequencing result: pending 09/18 COVID swab, result: detected 09/21 pt cc: chills, cough, diarrhea, fever, loss of taste or smell, myalgias, headache, fatigue, exposure: unknown 09/27 pt admit to medicine cc: covid, hypoxia dx: covid 19 pneumonia LOS: 4 days 09/27 CXR impression: Several EKG wires overlie the chest. There is a right internal jugular port catheter with tip in the region of the right atrium. An aortic valve stent graft is again seen. The heart is magnified by technique. Patchy bilateral alveolar opacities are seen distributed throughout the lungs, worrisome for Covid pneumonia. The visualized pleural spaces are well preserved. 09/27 CTA PE impression: 1. Negative for pulmonary embolus. 2. Known Covid pneumonia with diffuse groundglass infiltrates similar to chest radiograph performed earlier today. 09/27 US EXTREMITY VENOUS LTD impression: No evidence of acute or progressive deep venous thrombosis bilateral lower extremities. Chronic appearing nonocclusive/recanalized thrombus left popliteal vein initially imaged 10/2/2017 09/27 TROPONIN I <0.016 09/27 procalcitonin <0.05 09/27 ESR 31 09/27 DDIMER 7.00 09/27 bnp 51.7 09/27 ABG: i-pH 7.50, i-PC02 31.4, i-P02 73; i-HCO3 24.3 09/28 lactic acid 1.07 09/28 procalcitonin <0.05 09/28 FIBRINOGEN 469 09/28 DDIMER: 4.02 09/28 ESR 22 09/29 FIBRINOGEN: 342 09/29 DDIMER: 4.24 09/29 ESR 13 09/30 FIBRINOGEN: 250 09/30 DDIMER: 3,32 09/30 ESR 6 10/01 FIBRINOGEN: 226 10/01 DDIMER: 4.75 10/01 ESR 1
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases, Blood lactic acid, Blood pH increased, Brain natriuretic peptide normal, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/19, Pfizer, dose #2 07/13 COVID swab, result: not detected 08/31, Pfizer, dose #3 09/18 SARS-COV-2 Variant Sequencing result: pending 09/18 COVID swab, result: detected 09/21 pt cc: chills, cough, diarrhea, fever, loss of taste or smell, myalgias, headache, fatigue, exposure: unknown 09/27 pt admit to medicine cc: covid, hypoxia dx: covid 19 pneumonia LOS: 4 days 09/27 CXR impression: Several EKG wires overlie the chest. There is a right internal jugular port catheter with tip in the region of the right atrium. An aortic valve stent graft is again seen. The heart is magnified by technique. Patchy bilateral alveolar opacities are seen distributed throughout the lungs, worrisome for Covid pneumonia. The visualized pleural spaces are well preserved. 09/27 CTA PE impression: 1. Negative for pulmonary embolus. 2. Known Covid pneumonia with diffuse groundglass infiltrates similar to chest radiograph performed earlier today. 09/27 US EXTREMITY VENOUS LTD impression: No evidence of acute or progressive deep venous thrombosis bilateral lower extremities. Chronic appearing nonocclusive/recanalized thrombus left popliteal vein initially imaged 10/2/2017 09/27 TROPONIN I <0.016 09/27 procalcitonin <0.05 09/27 ESR 31 09/27 DDIMER 7.00 09/27 bnp 51.7 09/27 ABG: i-pH 7.50, i-PC02 31.4, i-P02 73; i-HCO3 24.3 09/28 lactic acid 1.07 09/28 procalcitonin <0.05 09/28 FIBRINOGEN 469 09/28 DDIMER: 4.02 09/28 ESR 22 09/29 FIBRINOGEN: 342 09/29 DDIMER: 4.24 09/29 ESR 13 09/30 FIBRINOGEN: 250 09/30 DDIMER: 3,32 09/30 ESR 6 10/01 FIBRINOGEN: 226 10/01 DDIMER: 4.75 10/01 ESR 1